Atjaunināt sīkdatņu piekrišanu

E-grāmata: Microvascular Disease in Diabetes [Wiley Online]

  • Formāts: 280 pages
  • Izdošanas datums: 22-Apr-2020
  • Izdevniecība: Wiley-Blackwell
  • ISBN-10: 1119309646
  • ISBN-13: 9781119309642
Citas grāmatas par šo tēmu:
  • Wiley Online
  • Cena: 203,65 €*
  • * this price gives unlimited concurrent access for unlimited time
  • Formāts: 280 pages
  • Izdošanas datums: 22-Apr-2020
  • Izdevniecība: Wiley-Blackwell
  • ISBN-10: 1119309646
  • ISBN-13: 9781119309642
Citas grāmatas par šo tēmu:

Presents comprehensive coverage of the many microvascular complications of diabetes

Diabetes remains one of the main causes, in the western world, of legal blindness, end stage renal disease, and amputation, despite the implementation of tight glycemic control and the great progress in the management and care of our patients. This book provides a useful and handy tool to professionals and students in the field of diabetes and its microvascular complications by integrating information from clinical settings as well as from the frontlines of diabetic research. It provides readers with up-to-date diagnostic criteria, classifications, and therapeutic approaches. and recent discoveries on mechanisms of disease, experimental therapeutic agents, and biomarkers of disease. 

Written by top experts in the field, Microvascular Disease in Diabetes offers in-depth chapters covering pathophysiology; the genetics of diabetic microvascular disease; and the epigenetics of diabetic microvascular disease. It then provides sections featuring both clinical and research information on diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, and diabetic foot. It also looks at coronary microvascular dysfunction and cerebral microvascular disease.

  • Integrates new and accessible material on diabetic microvascular comorbidities
  • Covers all relevant microvascular systems
  • Provides a much-needed resource synthesizing research and clinical applications to treating microvascular complications of diabetes
  • Presents current diagnostic criteria, classifications, and therapeutic approaches, as well as recent discoveries on the mechanisms of disease, experimental therapeutic agents, and biomarkers of disease

Assembled in an easily consultable manner, Microvascular Disease in Diabetes is an excellent text for investigators, clinicians, and students looking to improve their understanding of diabetic complications.

Foreword to: Microvascular Disease in Diabetes xv
Editor Biography xvii
List of Contributors xix
1 Introduction 1(4)
Andrea Giustina
Stefano Frara
References
3(2)
2 Pathophysiology 5(18)
Francesco Tecilazich
Introduction
5(1)
Anatomo-Physiology of Microvessels
5(1)
Regulation of Microvascular Tone
6(2)
Endothelial-Dependent Vasodilation
6(1)
Endothelial-Independent Vasodilation
6(1)
Nerve Axon Reflex (NARV)
7(1)
Myogenic Response
7(1)
Functional Hyperemia
7(1)
Venoarteriolar Response (VAR)
8(1)
Structural Changes in the Microcirculation
8(1)
Functional Changes in the Microcirculation
8(8)
Endothelial Dysfunction
8(1)
VSMC Dysfunction
9(1)
NARV Impairment
9(1)
Defective Myogenic Response
10(1)
Reduced Functional Hyperemia
10(1)
Endothelial Dysfunction
11(1)
Role of the Immune System and Leukostasis
11(1)
Role of Hyperglycemia
12(3)
AGES
12(1)
Polyol Pathway
12(1)
Oxidative Stress
13(1)
PKC
13(1)
Transforming Growth Factor (TGF)-β
14(1)
Hexosamine Pathway
14(1)
PARP
14(1)
ET-1
14(1)
Vasoconstrictor Prostanoid Synthesis
15(1)
Role of Insulin Resistance
15(1)
Role of Inflammation
15(1)
References
16(7)
3 Genetics of Diabetic Microvascular Disease 23(22)
Niina Sandholm
Carol Forsblom
Introduction
23(1)
Genetics of DKD
23(7)
Heritability of DKD
23(1)
Candidate Genes for DKD
24(1)
Linkage Studies for DKD
25(1)
Genome-Wide Association Studies on DKD
25(4)
Sequencing Efforts for DKD
29(1)
Genetics of Diabetic Retinopathy
30(3)
Heritability of Diabetic Retinopathy
30(1)
Candidate Genes for Diabetic Retinopathy
30(1)
Linkage Studies for Diabetic Retinopathy
31(1)
GWAS on Diabetic Retinopathy
31(2)
Sequencing Efforts for Diabetic Retinopathy
33(1)
Genetics of Diabetic Neuropathy
33(1)
Heritability of Diabetic Neuropathy
33(1)
Candidate Genes for Diabetic Neuropathy
33(1)
GWASs on Diabetic Neuropathy
34(1)
Future Directions
34(3)
Larger Studies Are Needed
34(1)
How to Define the Phenotype?
35(1)
Variability in the Phenotypic Definitions
35(1)
Criteria for Controls
36(1)
Do Genetics of Microvascular Complications in T1D and T2D Differ?
36(1)
Low-Frequency and Rare Variants May Affect Diabetic Complications
36(1)
Sequencing of Rare and Low-Frequency Variants
36(1)
Linkage Analysis with GWAS Data
37(1)
Genetics May Reveal Biology and Infer Causality
37(1)
Conclusions
37(1)
References
37(8)
4 Epigenetics of Diabetic Microvascular Disease 45(14)
Luciano Pirola
Diabetic Complications Include Microvascular and Macrovascular Injury
45(1)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study in Type 1 Diabetic Patients, and the UKPDS Study in Type 2 Diabetic Patients, Support the Existence of the Hyperglycemic Memory Phenomenon
46(1)
DCCT/EDIC Study
46(1)
The UKPDS Study
46(1)
Models of Hyperglycemic Memory
47(1)
Animal Models
47(1)
Cell Culture Models
48(1)
The "Epigenetic Code"
48(4)
DNA Methylation
49(1)
Histone Methylation in Models of Hyperglycemic Variability
49(1)
Epigenetic Changes in Microvascular Models of Glycemic Memory
50(2)
miRNAs Contribute to the Control of Glucose Homeostasis and Are Dysregulated in Diabetes
52(1)
Future Prospects
52(2)
References
54(5)
5 Diabetic Retinopathy - Clinical 59(20)
Francesco Bandello
Rosangela Lattanzio
Alessandro Marchese
Emanuela Aragona
Introduction
59(1)
Epidemiology
60(1)
Screening
60(1)
Risk Factors
61(1)
Clinical Patterns
61(8)
Non-Proliferative Diabetic Retinopathy (NPDR)
61(4)
Clinical Findings
62(2)
Diagnostic Tools
64(1)
Treatment Strategies
65(1)
Proliferative Diabetic Retinopathy (PDR)
65(4)
Clinical Findings
65(2)
Diagnostic Tools
67(1)
Treatment Strategies
67(2)
Diabetic Macular Edema (DME)
69(4)
Classification
70(31)
Clinical Findings
71(1)
Diagnostic Tools
71(1)
Treatment Strategies
71(2)
Conclusions
73(1)
References
74(5)
6 Diabetic Retinopathy - Research 79(6)
Gopalan Gnanaguru
Retina and Induction of Hyperglycemia
79(1)
Hyperglycemia and Retinal Microvasculature
80(1)
Hyperglycemia and Reactive Gliosis
80(1)
Hyperglycemia and Neurodegeneration
81(1)
Hyperglycemia and Inflammation
81(1)
References
82(3)
7 Diabetic Nephropathy - Clinical 85(12)
Gianpaolo Zerbini
Epidemiology
85(1)
Natural History
86(1)
Stages of DN
86(1)
Morphologic Changes
87(1)
Pathophysiology
88(1)
Clinical Course
89(1)
Treatment
90(1)
Primary Prevention
90(1)
Secondary Prevention
91(1)
Tertiary Prevention
91(1)
Perspectives
91(1)
References
92(5)
8 Diabetic Nephropathy - Research 97(14)
Silvia Maestroni
Gianpaolo Zerbini
Essential Hypertension and DN
97(2)
Role of Genetics in the Pathogenesis of DN
99(1)
Polyol Pathway and Non-Enzymatic Glycation
100(1)
Environment
100(1)
Perspectives
101(1)
Sodium-Glucose Cotransporter-2 (SGLT2) and DN
101(1)
B7-1 and DN
101(1)
Animal Models
102(1)
DN in Induced Model of Type 1 Diabetes Mellitus (T1DM)
102(1)
DN in Spontaneous Model of T1DM
103(1)
Ins2Akita Mice
103(1)
Non-Obese Diabetic (NOD) Mice
104(1)
OVE26 Friend leukemia virus B (FVB) Mice
104(1)
DN in Spontaneous Models of T2DM
105(1)
db/db Mice
105(1)
References
105(6)
9 Diabetic Neuropathy - Clinical 111(18)
Christopher H. Gibbons
Introduction
111(1)
Classification of Diabetic Neuropathies
111(11)
Distal Symmetric Polyneuropathy (DSPN)
112(2)
Diagnosis
113(1)
Management
113(1)
Small Fiber Neuropathy
114(2)
Diagnosis
115(1)
Management
115(1)
Autonomic Neuropathy
116(3)
Diagnosis
117(1)
Management
117(2)
Treatment-Induced Neuropathy of Diabetes (TIND)
119(1)
Diagnosis
119(1)
Management
120(1)
Diabetic Radiculoplexopathy
120(1)
Diagnosis
120(1)
Management
121(1)
Mononeuropathies
121(1)
Diagnosis
121(1)
Management
121(1)
Cranial Neuropathies
121(8)
Diagnosis
121(1)
Management
122(1)
Screening for Neuropathy
122(1)
Summary of Management of Diabetic Neuropathy
122(1)
References
123(6)
10 Diabetic Neuropathy - Research 129(28)
Krish Chandrasekaran
Lindsay A. Zilliox
James W. Russell
Basic and Translational Research in Diabetic Neuropathy
129(17)
Animal Models of Diabetic Neuropathy
129(2)
Basic Pathophysiology of Diabetic Neuropathy
131(9)
Changes in Redox Potential
131(2)
Role of Mitochondrial Dysfunction in Diabetic Neuropathy
133(4)
Protein Kinase C (PKC) and Neuropathy
137(1)
Advanced Glycation End Products
137(1)
Modifying Molecular Chaperones
138(1)
Inflammation and Neuropathy
138(1)
TGF-β and Neuropathy
138(1)
Metabotropic Glutamate Receptors (mGluRs) and Oxidative Injury
139(1)
Growth Factors and Diabetes
139(1)
Clinical Research in Diabetic Neuropathy
140(18)
Treatment of Hypertension
141(1)
Improved Glycemic Control
141(1)
Diet and Lifestyle Interventions
142(2)
Alpha-Lipoic Acid
144(1)
Benfotiamine and Neuropathy
145(1)
Treatment of Neuropathic Pain
145(1)
Acknowledgments
146(1)
References
147(10)
11 Diabetic Foot - Clinical 157(16)
Cristian Nicoletti
Introduction and Size of the Problem
157(1)
Pathogenesis of Diabetic Foot Complications
158(1)
Neuropathy
158(1)
Peripheral Vascular Disease
158(1)
Other Risk Factors
159(1)
Prevention
159(1)
Treatment
160(1)
Treatment of Neuropathic Diabetic Foot Ulcers: Offloading
160(1)
Treatment of PAD: Revascularization
161(2)
Diabetic Foot Infections (DFIs)
163(3)
Introduction
163(1)
Diagnosis
163(1)
Treatment
164(2)
Wound Healing
166(1)
Debridement
166(1)
Dressings
167(1)
Topical Negative Pressure Wound Therapy (NPWT)
167(1)
Other Topical Treatments
167(1)
References
167(6)
12 Diabetic Foot - Research 173(28)
Georgios Theocharidis
Aristidis Neves
Introduction
173(1)
Anatomy of the Skin and Microcirculation
174(1)
Structural Changes in the Microcirculation
174(1)
Functional Changes in the Microcirculation
175(1)
Functional Changes in the Diabetic Foot
176(8)
Vasodilation
176(3)
Endothelium-Dependent Vasodilation
177(1)
Endothelium-Independent Vasodilation
178(1)
Nerve Axon Reflex
179(1)
Mechanisms of Endothelial Dysfunction
180(4)
Endothelial Dysfunction and Hyperglycemia
180(2)
Endothelial Dysfunction and Insulin Resistance
182(1)
Endothelial Dysfunction and Inflammation
183(1)
Pathophysiology of Diabetic Wound Healing
184(2)
Hyperglycemia
184(1)
Chronic Inflammation
184(2)
Impaired Angiogenesis and Vasculogenesis
186(1)
Hypoxia
186(1)
Impaired Neuropeptide Signaling
186(1)
Adjunctive Treatment Options
186(3)
Bioengineered Skin Substitutes
187(1)
Growth Factors
187(1)
Hyperbaric Oxygen Therapy
188(1)
Negative Pressure Wound Therapy
188(1)
Electrical Stimulation and Shockwave Therapy
189(1)
Future Therapeutic Perspectives
189(2)
Gene Therapies
189(1)
Stem Cell Therapies
189(1)
Norleu3-Angiotensin-(1-7)
190(1)
Neuropeptides
190(1)
Cytokine Inhibition
190(1)
Conclusion
191(1)
References
191(10)
13 Coronary Microvascular Dysfunction in Diabetes - Clinical and Research 201(20)
Guglielmo Gallone
Francesco Moroni
Marco Magnoni
Introduction
201(4)
Clinical Classification and Mechanisms of CMD
202(1)
CMD in Diabetic Patients
203(2)
Clinical Assessment of CMD
205(7)
Non-Invasive Imaging Technique for the Assessment of CMD
205(2)
Transthoracic Doppler Evaluation
205(1)
Contrast Echocardiography
206(1)
Cardiovascular Magnetic Resonance (CMR) Imaging
206(1)
Positron Emission Tomography (PET)
207(1)
Invasive Techniques for the Evaluation of CBF
207(3)
Indicator Dilution-Based Methods
207(1)
Thermodilution
208(1)
Gas Wash Out Method
208(1)
Intracoronary Doppler Flow Wire
208(2)
Treatment for CMD
210(14)
The Effects of Glucose-Lowering Drugs on CMD
211(1)
Future Perspectives for the Treatment of CMD in Diabetes
211(1)
References
212(9)
14 Cerebral Microvascular Disease in Diabetes - Clinical and Research 221
Eelco van Duinkerken
Richard G. IJzerman
Introduction
221(1)
Postmortem Studies of the Brain in Diabetes
222(1)
Cerebral Small Vessel Disease on MRI
223(1)
MRI-Measured Cerebral Small Vessel Disease in Type 1 Diabetic Patients
224(3)
White Matter Hyperintensities
224(2)
Cerebral Microbleeds
226(1)
Summary
226(1)
Type 2 Diabetes and Cerebral Small Vessel Disease
227(4)
Lacunar Infarcts
227(1)
White Matter Hyperintensities
228(2)
Cerebral Microbleeds
230(1)
Synthesis
230(1)
Clinical Impact of Cerebral Small Vessel Disease in Diabetes
231(4)
Cognitive Functioning
231(2)
Stroke
233(1)
Dementia
234(1)
The Influence of Microvascular Disease on the Structure and Functioning of the Diabetic Brain
235(4)
Type 1 Diabetes
236(1)
Type 2 Diabetes
237(2)
Conclusions and Future Directions
239(1)
References
240
Index 24
FRANCESCO TECILAZICH, MD, PhD, is a physician and scientist in the Endocrinology and Metabolic Diseases department of the Ospedale San Raffaele—Vita Salute San Raffaele University in Milan, Italy.